Tag Archives: lly

Lilly Diabetes Drug Jardiance Cuts Death Rate By 32%

Shares of Eli Lilly (LLY) jumped to a more than 14-year high Thursday as the company presented more evidence that its diabetes drug Jardiance reduces death from heart failure. At the annual European Association for the Study of Diabetes, Lilly and partner Boehringer Ingelheim presented details on the massive Empa-Reg Outcome Trial studying the long-term cardiovascular effects of Jardiance, which they first headlined last month. Lilly and Ingelheim

Lilly Diabetes Drug Jardiance Improves Heart Health

Big pharma Eli Lilly (LLY) and its partner Boehringer Ingelheim said Thursday that their diabetes drug Jardiance succeeded in lowering the risk of death from cardiovascular disease in a massive three-year study, sending Lilly stock up sharply. Detailed results are being held for a medical meeting on Sept. 17, but Eli Lilly and Boehringer did say the Empa-Reg Outcome trial, which included more than 7,000 participants in 42 countries, achieved its

Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

Big pharmas Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) both soundly beat Q2 earnings estimates Thursday morning. Both also raised guidance, but not as much as their quarterly beats seemed to warrant. Lilly’s profit, excluding one-time items, rose 22% over the year-earlier quarter to 90 cents a share, beating analysts’ consensus by 16 cents, according to Thomson Reuters. Revenue rose 1% to $4.98 billion, where analysts had expected a slight